GGrantIndex
Sort

51,593 grants matching hepatitis

ADULT AIDS CLINICAL TRIALS UNIT

$1,667,113
New York University School Of Medicine · U01 · FY2003 · AI

Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)

$1,667,046
Mai Tuyet Pho · University Of Chicago · UH3 · FY2021 · DA

Southern California Research Center for ALPD and Cirrhosis

$1,666,183
Hidekazu Tsukamoto · University Of Southern California · P50 · FY2025 · AA

Multidisciplinary approach to study of patients with Severe Alcoholic Hepatitis Undergoing Liver Transplantation

$1,665,534
Andrew M Cameron · Johns Hopkins University · P50 · FY2020 · AA

Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)

$1,662,862
Mai Tuyet Pho · University Of Chicago · UH3 · FY2020 · DA

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$1,662,693
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Southern California Research Center for ALPD and Cirrhosis

$1,661,331
Hidekazu Tsukamoto · University Of Southern California · P50 · FY2012 · AA

IeDEA West -Africa collaboration

$1,661,149
Francois Dabis · Adera · U01 · FY2015 · AI

IeDEA West -Africa collaboration

$1,661,149
Francois Dabis · Adera · U01 · FY2014 · AI

Clinical Trials Network: Pacific Northwest Node

$1,660,257
Mary Akiko Hatch · University Of Washington · UG1 · FY2024 · DA

Clinical Genomics and Experimental Therapeutics

$1,659,842
Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA

A-Z Clinical Trials Unit

$1,659,641
Paul A. Goepfert · University Of Alabama At Birmingham · UM1 · FY2024 · AI

Liver Lung Interactions in Lung Inflammation

$1,659,607
Vanderbilt University · P01 · FY2002 · HL

Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment

$1,657,600
Luis J. Montaner · Wistar Institute · R01 · FY2020 · DA

Epidemiology and Natural History of Cancer-Associated Viruses

$1,656,987
Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

ADULT AIDS CLINICAL TRIALS UNIT

$1,655,127
New York University School Of Medicine · U01 · FY2002 · AI

Viral Vector Core

$1,653,435
Negin Martin · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES

IeDEA West -Africa collaboration

$1,653,274
Francois Dabis · Adera · U01 · FY2011 · AI

Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment

$1,652,477
Luis J. Montaner · Wistar Institute · R01 · FY2022 · DA

Molecular Biology and Genetics of Tumor Viruses

$1,652,465
University Of Wisconsin Madison · P01 · FY2003 · CA

National Neurological AIDS Bank (NNAB)

$1,652,260
University Of California Los Angeles · R24 · FY2004 · NS

HOPE in Action: A Clinical Trial of HIV-to-HIV Liver Transplantation

$1,651,121
Christine Marie Durand · Johns Hopkins University · U01 · FY2021 · AI

Molecular Regulation Of RNA Metabolism

$1,650,971
Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD

B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses

$1,650,200
Benjamin Doranz · Integral Molecular · N01 · FY2013 · AI

Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses

$1,649,808
Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI